EarningsQ3 2024 Earnings Report

Outlook Therapeutics (41O) Q3 2024 Earnings Report

8 Followers

DE:41O Q3 2024 EPS Results

Actual EPS-€0.72

Consensus EPS-€0.89

Beat/MissBeat by +€0.18

One Year Ago EPS-€1.38

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ3 2024

Date08/14/2024

TimeBefore Open

Conference CallWednesday, August 14, 2024

DE:41O Upcoming Earnings

Outlook Therapeutics's next earnings date is estimated for December 18, 2026, based on past reporting schedules.

DE:41O Q3 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Dec 18, 2026	2026 (Q4)	-0.06 / -	-0.052	―
Aug 14, 2026	2026 (Q3)	-0.07 / -0.08	-0.38	79.55% (+0.30)
May 15, 2026	2026 (Q2)	-0.10 / -0.14	-0.345	60.00% (+0.21)
Feb 17, 2026	2026 (Q1)	-0.20 / -0.19	-0.768	75.28% (+0.58)
Dec 19, 2025	2025 (Q4)	-0.22 / -0.05	-0.759	93.18% (+0.71)
Aug 14, 2025	2025 (Q3)	-0.30 / -0.38	-0.716	46.99% (+0.34)
May 15, 2025	2025 (Q2)	-0.47 / -0.35	-1.338	74.19% (+0.99)
Feb 14, 2025	2025 (Q1)	-0.66 / -0.77	-0.69	-11.25% (-0.08)
Dec 27, 2024	2024 (Q4)	-0.69 / -0.76	-0.863	12.00% (+0.10)
Aug 14, 2024	2024 (Q3)	-0.89 / -0.72	-1.381	48.13% (+0.66)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed